Global Left Ventricular Dysfunction - API Manufacturers, Marketed and Phase III Drugs Landscape 2018 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 19, 2018--The “Left Ventricular Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.The ‘Left Ventricular Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018’ report provides comprehensive insights about marketed and Phase III products for Left Ventricular Dysfunction. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country.
Global API Manufacturers of Marketed Products for Left Ventricular Dysfunction
Coverage of API manufacturers for Left Ventricular Dysfunction marketed products spanning across United States, Europe, China and India. The manufacturers’ details include manufacturers’ name along with their location.
Emerging Phase III products for Left Ventricular Dysfunction
This report provides a comprehensive understanding of the emerging Phase III therapies for Left Ventricular Dysfunction which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.
Key Topics Covered:
1. Report Introduction
2. Left Ventricular Dysfunction: OverviewRisk FactorsCausesSymptomsPathophysiologyPrognosisDiagnosisTreatment
3. Comparative Analysis of Marketed and Emerging Products
4. Marketed TherapiesProduct DescriptionRoute of SynthesisMechanism of ActionPharmacologyPharmacodynamicsPharmacokineticsAdverse ReactionsClinical TrialsRegulatory MilestonesProduct Development ActivitiesUnited StatesEuropeHistorical Global SalesForecasted Global Sales
5. Emerging Therapies (Phase III)Product DescriptionResearch and DevelopmentProduct Development Activities
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/6mng35/global_left?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181219005332/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Drugs
INDUSTRY KEYWORD: HEALTH CARDIOLOGY PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 12/19/2018 06:43 AM/DISC: 12/19/2018 06:43 AM